Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
A touch of MS: Therapeutic mislabeling.
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.
First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
The benefits of exercise training in multiple sclerosis.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Naltrexone
Multiple sclerosis causing a partial sixth nerve palsy.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Psoriasis during natalizumab treatment for multiple sclerosis.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
The microglial sensome revealed by direct RNA sequencing.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.

Pages